XML 21 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2017
Dec. 31, 2016
Assets    
Cash and cash equivalents [1] $ 87.9 $ 30.5
Accounts receivable, net of allowance of $0.4 at 2017 and $0.3 at 2016 100.0 89.8
Inventories, net 160.0 151.2
Prepaid and other current assets 20.8 23.7
Current assets 368.7 295.2
Property, plant and equipment, net 438.5 422.8
Goodwill 12.4 12.4
Other intangibles, net 4.9 7.3
Deferred income taxes 3.4 3.4
Restricted investment 71.3 69.7
Other assets 30.4 22.0
Total Assets 929.6 832.8
Liabilities and equity    
Accounts payable 83.1 79.2
Accrued expenses 20.0 19.3
Accrued payroll and employee benefits 39.2 25.6
Current maturities of long-term debt 9.4 7.5
Income taxes payable 1.5 5.3
Current liabilities 153.2 136.9
Long-term debt including capital lease obligations 444.0 481.3
Deferred income taxes 41.3 69.8
Other liabilities 13.2 10.2
Total Liabilities 651.7 698.2
Commitments and contingencies (Note 18)
Equity    
Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; no issued and outstanding at 2017 and 2016) 0.0 0.0
Common stock (par value $0.01 per share; 300,000,000 shares authorized; 42,208,973 and 42,116,430 issued and 42,089,103 and 42,115,824 outstanding at 2017 and 2016, respectively) 0.4 0.4
Additional paid-in capital 142.8 16.0
Retained earnings 140.1 129.9
Accumulated other comprehensive loss (11.7) (19.0)
Treasury stock, common stock, at cost (119,870 and 606 shares at 2017 and 2016, respectively) (7.7) (0.3)
Total Ingevity stockholders' equity 263.9 127.0
Noncontrolling interests 14.0 7.6
Total Equity 277.9 134.6
Total Liabilities and Equity $ 929.6 $ 832.8
[1] There was no restricted cash for the periods ended December 31, 2017, 2016 and 2015, respectively.